---
figid: PMC5406893__13073_2017_429_Fig7_HTML
figtitle: Summary of the survival and growth phenotypes in breast cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5406893
filename: 13073_2017_429_Fig7_HTML.jpg
figlink: /pmc/articles/PMC5406893/figure/Fig7/
number: F7
caption: Summary of the survival and growth phenotypes in breast cancer. The survival
  phenotype is characterized by high HER2, IGF1R, and AKT pathway activation, high
  expression of pro-apoptotic BIM, low expression of anti-apoptotic MCL-1, and response
  to HER2, AKT, PI3K, and mTOR inhibitors. The growth phenotype is characterized by
  high EGFR, KRAS, and RAF1 activation, high expression of MCL-1, low expression of
  BIM, and response to EGFR/MEK-targeted therapies and chemotherapies
papertitle: Activity of distinct growth factor receptor network components in breast
  tumors uncovers two biologically relevant subtypes.
reftext: Mumtahena Rahman, et al. Genome Med. 2017;9:40.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9302001
figid_alias: PMC5406893__F7
figtype: Figure
redirect_from: /figures/PMC5406893__F7
ndex: 02c69efc-dea6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5406893__13073_2017_429_Fig7_HTML.html
  '@type': Dataset
  description: Summary of the survival and growth phenotypes in breast cancer. The
    survival phenotype is characterized by high HER2, IGF1R, and AKT pathway activation,
    high expression of pro-apoptotic BIM, low expression of anti-apoptotic MCL-1,
    and response to HER2, AKT, PI3K, and mTOR inhibitors. The growth phenotype is
    characterized by high EGFR, KRAS, and RAF1 activation, high expression of MCL-1,
    low expression of BIM, and response to EGFR/MEK-targeted therapies and chemotherapies
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - IGF1R
  - KRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - RAF1
  - RNASE3
  - BAD
  - BCL2L11
  - MCL1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - Cancer
  - Lung cancer
---
